SCOPUS 정보 검색 플랫폼

Volumn 14, Issue 6, 2000, Pages 691-693

Calcium-dependent vasorelaxant capacity of levosimendan in porcine and human epicardial coronary artery preparations [1]

(4) Krassoi I a Pataricza, J b Kun, A b Papp, J G b

a INSTITUTE OF EXPERIMENTAL MEDICINE (Hungary)

b UNIVERSITY OF SZEGED (Hungary)

Author keywords

Extracellular calcium; Levosimendan; Porcine and human epicardial coronary arteries; Smooth muscle tone

Indexed keywords

LEVOSIMENDAN;

ANIMAL TISSUE; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; HUMAN; HUMAN TISSUE; LETTER; NONHUMAN; PRIORITY JOURNAL; SWINE; VASODILATATION;

ADOLESCENT; ADULT; ANIMALS; CALCIUM; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDRAZONES; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; PERICARDIUM; PYRIDAZINES; SWINE; VASODILATION; VASODILATOR AGENTS;

EID: 0034467846 PISSN: 09203206 EISSN: None Source Type: Journal
DOI: 10.1023/A:1007883402379 Document Type: Letter

Times cited : (15)

References (10)

1
- 0032818907
- Minimal effects of levosimendan on coronary artery smooth muscle tone
- (1999) Cardiovasc Drugs Ther , vol.13 , pp. 357-358
- Köppel, H.¹ Holzmann, S.² Pilger, E.³ Klein, W.⁴ Gasser, R.⁵

2
- 0029098682
- Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan
- (1995) J Mol Cell Cardiol , vol.27 , pp. 1859-1866
- Haikala, H.¹ Kaivola, J.² Nissinen, E.³ Wall, P.⁴ Levijoki, J.⁵ Lindén, I.-B.⁶

3
- 0029585067
- Pharmacokinetics of levosimendan in healthy volunteers patients with congestive heart failure
- (1995) J Cardiovasc Pharmacol , vol.26
- Sandell, E.-P.¹ Häyhä, M.² Antila, S.³

4
- 0004156161
- Philadelphia: WB Saunders
- (1956) Handbook of Biological Data
- Spector, W.¹

5
- 0343049171
- Comparison of the vasorelaxant effect of cromakalim and the new inodilator, levosimendan, in human isolated portal vein
- (2000) J Pharm Pharmacol , vol.52 , pp. 213-217
- Pataricza, J.¹ Hohn, J.² Petri, A.³ Balogh, Á.⁴ Papp, J.Gy.⁵

6
- 0028245011
- A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts
- (1994) Br J Pharmacol , vol.112 , pp. 757-762
- Rump, A.F.¹ Acar, D.² Klaus, W.³

7
- 0030955524
- The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan
- (1997) Cardiovasc Res , vol.34 , pp. 536-546
- Haikala, H.¹ Kaheinen, P.² Levijoki, J.³ Linden, I.B.⁴

8
- 0031976338
- Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting
- (1998) Eur Heart J , vol.19 , pp. 660-668
- Lilleberg, J.¹ Nieminen, M.S.² Akkila, J.³

9
- 0030608872
- The vasodilator levosimendan hyperpolarizes and activates a glibenclamide-sensitive potassium channel in vascular smooth muscle cells
- (1996) Eur J Pharmacol , vol.333 , pp. 249-259
- Yokoshiki, H.¹ Katsube, Y.² Sunagawa, M.³ Sperelakis, N.⁴

10
- 0000571714
- Effect of potassium channel modulating drugs on isolated smooth muscle
- Szekeres L, Papp JGy, eds. Berlin Springer-Verlag
- (1994) Handbook of Experimental Pharmacology Volume 111, Pharmacology of Smooth Muscle , vol.3 , pp. 469-531
- Edwards, G.¹ Weston, A.H.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.